DK1087750T3 - Farmaceutiske formuleringer til aerosoler med to eller flere aktive stoffer - Google Patents

Farmaceutiske formuleringer til aerosoler med to eller flere aktive stoffer

Info

Publication number
DK1087750T3
DK1087750T3 DK99928458T DK99928458T DK1087750T3 DK 1087750 T3 DK1087750 T3 DK 1087750T3 DK 99928458 T DK99928458 T DK 99928458T DK 99928458 T DK99928458 T DK 99928458T DK 1087750 T3 DK1087750 T3 DK 1087750T3
Authority
DK
Denmark
Prior art keywords
aerosols
active substances
pharmaceutical formulations
formulations
pharmaceutical
Prior art date
Application number
DK99928458T
Other languages
English (en)
Inventor
Daniel P Mcnamara
George A Destefano
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26046888&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1087750(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from DE1998127178 external-priority patent/DE19827178A1/de
Priority claimed from DE1998142963 external-priority patent/DE19842963A1/de
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Application granted granted Critical
Publication of DK1087750T3 publication Critical patent/DK1087750T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/12—Mucolytics
DK99928458T 1998-06-18 1999-06-08 Farmaceutiske formuleringer til aerosoler med to eller flere aktive stoffer DK1087750T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE1998127178 DE19827178A1 (de) 1998-06-18 1998-06-18 Pharmazeutische Formulierung für Aerosole mit zwei oder mehr Wirkstoffen
DE1998142963 DE19842963A1 (de) 1998-09-19 1998-09-19 Pharmazeutische Formulierung für Aerosole mit zwei oder mehr Wirkstoffen
PCT/US1999/012785 WO1999065464A1 (en) 1998-06-18 1999-06-08 Pharmaceutical formulations for aerosols with two or more active substances

Publications (1)

Publication Number Publication Date
DK1087750T3 true DK1087750T3 (da) 2004-01-26

Family

ID=26046888

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99928458T DK1087750T3 (da) 1998-06-18 1999-06-08 Farmaceutiske formuleringer til aerosoler med to eller flere aktive stoffer

Country Status (33)

Country Link
EP (1) EP1087750B1 (da)
JP (1) JP2003522102A (da)
KR (1) KR100600423B1 (da)
CN (1) CN1161104C (da)
AR (1) AR019690A1 (da)
AT (1) ATE253896T1 (da)
AU (1) AU759222B2 (da)
BG (1) BG65252B1 (da)
BR (1) BR9911351A (da)
CA (1) CA2335065C (da)
CO (1) CO5070580A1 (da)
CZ (1) CZ300910B6 (da)
DE (1) DE69912781T2 (da)
DK (1) DK1087750T3 (da)
EE (1) EE04450B1 (da)
ES (1) ES2211108T3 (da)
HK (1) HK1037974A1 (da)
HR (1) HRP20000867B1 (da)
HU (1) HU229064B1 (da)
ID (1) ID27554A (da)
IL (2) IL140353A0 (da)
ME (1) ME00838B (da)
MY (1) MY121073A (da)
NO (1) NO329416B1 (da)
NZ (1) NZ509418A (da)
PL (1) PL193695B1 (da)
PT (1) PT1087750E (da)
RS (1) RS49977B (da)
RU (1) RU2218152C2 (da)
SK (1) SK284756B6 (da)
TR (1) TR200003721T2 (da)
TW (1) TW528606B (da)
WO (1) WO1999065464A1 (da)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9616237D0 (en) 1996-08-01 1996-09-11 Norton Healthcare Ltd Aerosol formulations
GB2332372B (en) * 1997-12-08 2002-08-14 Minnesota Mining & Mfg Pharmaceutical aerosol compositions
DZ2947A1 (fr) 1998-11-25 2004-03-15 Chiesi Farma Spa Inhalateur à compteur de dose sous pression.
US7214687B2 (en) 1999-07-14 2007-05-08 Almirall Ag Quinuclidine derivatives and medicinal compositions containing the same
ES2165768B1 (es) 1999-07-14 2003-04-01 Almirall Prodesfarma Sa Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
IT1313553B1 (it) 1999-07-23 2002-09-09 Chiesi Farma Spa Formulazioni ottimizzate costituite da soluzioni di steroidi dasomministrare per inalazione.
JP2003509359A (ja) 1999-09-11 2003-03-11 グラクソ グループ リミテッド プロピオン酸フルチカゾンの医薬製剤
EP1523976A3 (en) * 1999-11-23 2005-06-22 Glaxo Group Limited Pharmaceutical formulations of salmeterol
ES2238334T3 (es) * 1999-12-24 2005-09-01 Glaxo Group Limited Formulacion farmaceutica en aerosol de salmeterol y propionato de fluticasona.
IT1317846B1 (it) 2000-02-22 2003-07-15 Chiesi Farma Spa Formulazioni contenenti un farmaco anticolinergico per il trattamentodella broncopneumopatia cronica ostruttiva.
GB0008485D0 (en) * 2000-04-07 2000-05-24 Glaxo Group Ltd Pharmaceutical compositions
WO2001089480A1 (en) * 2000-05-22 2001-11-29 Chiesi Farmaceutici S.P.A. Stable pharmaceutical solution formulations for pressurised metered dose inhalers
DE10062712A1 (de) * 2000-12-15 2002-06-20 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen auf der Basis von Anticholinergika und Corticosteroiden
US20030055026A1 (en) 2001-04-17 2003-03-20 Dey L.P. Formoterol/steroid bronchodilating compositions and methods of use thereof
DE10130371A1 (de) * 2001-06-23 2003-01-02 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen auf der Basis von Anticholinergika, Corticosteroiden und Betamimetika
PT1446119E (pt) 2001-09-18 2006-07-31 Nycomed Danmark Aps Substancias que contem ipratropio e xilometazolina na sua composicao para o tratamento da constipacao comum
JP2010184937A (ja) * 2001-10-26 2010-08-26 Dey Lp 慢性閉塞性肺疾患の症状を緩和するためのアルブテロールおよびイプラトロピウム吸入溶液、キット、吸入溶液を中に有する１容器を作成する方法、および、吸入溶液を作成する方法
GB0207899D0 (en) * 2002-04-05 2002-05-15 3M Innovative Properties Co Formoterol and cielesonide aerosol formulations
EP1915985A1 (en) * 2003-03-20 2008-04-30 Boehringer Ingelheim Pharmaceuticals Inc. Formulation for a Metered Dose Inhaler Using Hydro-Fluoro-Alkanes as Propellants
TWI359675B (en) 2003-07-10 2012-03-11 Dey L P Bronchodilating β-agonist compositions
US9308199B2 (en) * 2004-04-29 2016-04-12 Honeywell International Inc. Medicament formulations
EP1595531A1 (en) 2004-05-13 2005-11-16 CHIESI FARMACEUTICI S.p.A. Stable pharmaceutical solution formulations for pressurized metered dose inhalers
CN101175479A (zh) * 2005-03-16 2008-05-07 霍尼韦尔国际公司 药物递送制剂、装置和方法
DE102006053374A1 (de) * 2006-02-09 2007-08-16 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmazeutische Formulierung für Aerosole mit zwei oder mehr Wirkstoffen und mindestens einer oberflächenaktiven Substanz
DE102006017320A1 (de) 2006-04-11 2007-10-18 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosolsuspensionsformulierungen mit TG 227 ea oder TG 134 a als Treibmittel
US8061350B2 (en) 2006-06-02 2011-11-22 Boehringer Ingelheim Pharma Gmbh & Co. Kg Process and device for dosing pharmaceutical agents
US20070286814A1 (en) * 2006-06-12 2007-12-13 Medispray Laboratories Pvt. Ltd. Stable aerosol pharmaceutical formulations
ES2298049B1 (es) 2006-07-21 2009-10-20 Laboratorios Almirall S.A. Procedimiento para fabricar bromuro de 3(r)-(2-hidroxi-2,2-ditien-2-ilacetoxi)-1-(3-fenoxipropil)-1-azoniabiciclo (2.2.2) octano.
EP2077132A1 (en) 2008-01-02 2009-07-08 Boehringer Ingelheim Pharma GmbH & Co. KG Dispensing device, storage device and method for dispensing a formulation
EP2100599A1 (en) 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
EP2100598A1 (en) 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
EP2408500B1 (en) 2009-03-17 2015-04-29 Boehringer Ingelheim International GmbH Dispensing device, and storage device for dispensing a formulation
US10011906B2 (en) 2009-03-31 2018-07-03 Beohringer Ingelheim International Gmbh Method for coating a surface of a component
EP2432531B1 (de) 2009-05-18 2019-03-06 Boehringer Ingelheim International GmbH Adapter, inhalationseinrichtung und zerstäuber
BR112012012475B1 (pt) 2009-11-25 2020-03-03 Boehringer Ingelheim International Gmbh Nebulizador
US10016568B2 (en) 2009-11-25 2018-07-10 Boehringer Ingelheim International Gmbh Nebulizer
WO2011064163A1 (en) 2009-11-25 2011-06-03 Boehringer Ingelheim International Gmbh Nebulizer
EP3020393B1 (en) 2009-12-16 2020-10-07 3M Innovative Properties Company Formulations and methods for controlling mdi particle size delivery
JP5874724B2 (ja) 2010-06-24 2016-03-02 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ネブライザ
WO2012130757A1 (de) 2011-04-01 2012-10-04 Boehringer Ingelheim International Gmbh Medizinisches gerät mit behälter
EP2510928A1 (en) 2011-04-15 2012-10-17 Almirall, S.A. Aclidinium for use in improving the quality of sleep in respiratory patients
US9827384B2 (en) 2011-05-23 2017-11-28 Boehringer Ingelheim International Gmbh Nebulizer
WO2013152894A1 (de) 2012-04-13 2013-10-17 Boehringer Ingelheim International Gmbh Zerstäuber mit kodiermitteln
EP2835146B1 (en) 2013-08-09 2020-09-30 Boehringer Ingelheim International GmbH Nebulizer
US9744313B2 (en) 2013-08-09 2017-08-29 Boehringer Ingelheim International Gmbh Nebulizer
ES2874029T3 (es) 2014-05-07 2021-11-04 Boehringer Ingelheim Int Nebulizador
EA032850B1 (ru) 2014-05-07 2019-07-31 Бёрингер Ингельхайм Интернациональ Гмбх Контейнер, небулайзер и способ изготовления контейнера
SI3139982T1 (sl) 2014-05-07 2022-05-31 Boehringer Ingelheim International Gmbh Razpršilnik
WO2020152548A1 (en) * 2019-01-24 2020-07-30 Glenmark Pharmaceuticals Limited Stable aerosol inhalation compositions of formoterol

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8828477D0 (en) * 1988-12-06 1989-01-05 Riker Laboratories Inc Medical aerosol formulations
DK0673240T3 (da) * 1992-12-09 1999-10-11 Boehringer Ingelheim Pharma Stabiliserede medicinske aerosolopløsningsformuleringer
US5589156A (en) * 1994-05-02 1996-12-31 Henry; Richard A. Prilocaine and hydrofluourocarbon aerosol preparations
US5603918A (en) * 1995-06-09 1997-02-18 Boehringer Ingelheim Pharmaceuticals, Inc. Aerosol composition of a salt of ipratropium and a salt of albuterol
EP0914143A1 (en) * 1996-07-08 1999-05-12 Rhone-Poulenc Rorer Limited Medicinal cyclosporin-a aerosol solution formulation

Also Published As

Publication number Publication date
EE04450B1 (et) 2005-04-15
EE200000759A (et) 2002-04-15
HRP20000867B1 (en) 2010-10-31
AU759222B2 (en) 2003-04-10
ATE253896T1 (de) 2003-11-15
BG65252B1 (bg) 2007-10-31
AR019690A1 (es) 2002-03-13
JP2003522102A (ja) 2003-07-22
IL140353A0 (en) 2002-02-10
MY121073A (en) 2005-12-30
HU229064B1 (en) 2013-07-29
PT1087750E (pt) 2004-02-27
CO5070580A1 (es) 2001-08-28
CZ300910B6 (cs) 2009-09-09
BG105033A (en) 2001-09-28
ES2211108T3 (es) 2004-07-01
KR20010072621A (ko) 2001-07-31
TW528606B (en) 2003-04-21
HUP0104734A2 (hu) 2002-05-29
DE69912781D1 (de) 2003-12-18
IL140353A (en) 2006-09-05
CN1307470A (zh) 2001-08-08
TR200003721T2 (tr) 2001-06-21
HRP20000867A2 (en) 2001-10-31
AU4552199A (en) 2000-01-05
CN1161104C (zh) 2004-08-11
RU2218152C2 (ru) 2003-12-10
NO20006318L (no) 2001-01-30
RS49977B (sr) 2008-09-29
ME00838B (me) 2008-09-29
NZ509418A (en) 2003-06-30
SK19392000A3 (sk) 2001-07-10
CA2335065A1 (en) 1999-12-23
CZ20004750A3 (en) 2001-05-16
SK284756B6 (sk) 2005-11-03
PL193695B1 (pl) 2007-03-30
YU80000A (sh) 2003-04-30
NO329416B1 (no) 2010-10-18
HUP0104734A3 (en) 2003-05-28
HK1037974A1 (en) 2002-03-01
EP1087750A1 (en) 2001-04-04
WO1999065464A1 (en) 1999-12-23
DE69912781T2 (de) 2004-10-21
NO20006318D0 (no) 2000-12-12
CA2335065C (en) 2008-06-03
ID27554A (id) 2001-04-12
EP1087750B1 (en) 2003-11-12
KR100600423B1 (ko) 2006-07-13
PL345685A1 (en) 2002-01-02
BR9911351A (pt) 2001-03-13

Similar Documents

Publication Publication Date Title
DK1087750T3 (da) Farmaceutiske formuleringer til aerosoler med to eller flere aktive stoffer
DK0876815T3 (da) Lægemiddel-indgivelsessystem for to eller flere aktive stoffer
BR9807848B1 (pt) Composto de arilsulfonamidas e análogos, bem como composição farmacêutica e uso dos mesmos.
DK1073417T3 (da) Farmaceutisk aerosolformulering
DK1001813T3 (da) Farmaceutiske formuleringer indeholdende voriconazol
NO992339D0 (no) Farmas°ytiske formuleringer
NO990594L (no) Farmas°ytisk aerosolsammensetning
ATE235225T1 (de) Neue arzneimittel enthaltend uridintriphosphat
DK1083790T3 (da) Retardformuleringer af aktive stoffer til plantebeskyttelse
ID30032A (id) Formulasi farmasi
ITMI991308A0 (it) Procedimento per coadiuvare la condotta di volo
SI1087750T1 (en) Pharmaceutical formulations for aerosols with two or more active substances
DK1054666T3 (da) Væskeformig farmaceutisk formulering, der indeholder zotepin
DE69810442D1 (de) Anordnung zur verabreichung von medikamenten
BR1100782A (pt) Fenilimidazolidinas substituìdas, sua aplicação como medicamentos e as composições farmacêuticas que as contêm
SE9803952D0 (sv) Pharmaceutical formulation